Not logged in
  Home   Markets   Shares   Funds   Portfolio   Toolbox   Charting   Alerts   Directory   
 Admin   

Thu 7 Jun 2012, 16:40 APN - Aspen Pharmacare Holdings Limited - Changes in aspen`s Black Economic
APN
APN                                                                             
APN - Aspen Pharmacare Holdings Limited - Changes in aspen`s Black Economic     
Empowerment ("BEE") shareholding                                                
Aspen Pharmacare Holdings Limited                                               
(Incorporated in the Republic of South Africa)                                  
(Registration number 1985/002935/06)                                            
Share code: APN & ISIN: ZAE000066692                                            
("Aspen")                                                                       
CHANGES IN ASPEN`S BLACK ECONOMIC EMPOWERMENT ("BEE") SHAREHOLDING              
1. Introduction                                                                 
In May 2005, the shareholders of Aspen approved a scheme of arrangement to      
facilitate the acquisition of ordinary shares in Aspen ("Aspen Shares") by      
Imithi Investments (Proprietary) Limited ("Imithi"), the shareholders of        
which comprise a grouping of broadbased BEE entities (the "BEE                  
Transaction"). The BEE Transaction was designed with the objective of           
ensuring that a meaningful portion of Aspen`s equity is owned by black          
people and that black people have a meaningful role in Aspen`s operations,      
management and development.                                                     
Pursuant to the BEE Transaction, Imithi acquired 13 400 000 new Aspen           
Shares, representing 3.1% of the Aspen Shares currently in issue, and 17 600    
000 new variable rate, voting, convertible, redeemable, cumulative A            
preference shares (the "Aspen Preference Shares").                              
Aspen is pleased that its commitment to BEE and the strategic relationship      
forged with Imithi has resulted in significant value creation for both          
parties.                                                                        
2. Sale of Aspen Shares                                                         
In order to facilitate the redemption of its funding obligations, Imithi has    
concluded a process of disposing of               9 839 276 Aspen Shares        
(the "Sale"), as allowed for in terms of the agreements governing the BEE       
Transaction.                                                                    
The proceeds of the Sale will be used by Imithi to redeem all of its            
outstanding preference share funding and to settle any transaction costs and    
taxes associated with the Sale.                                                 
The Sale was conducted with the full knowledge and prior consent of the         
Aspen board of directors.                                                       
3. Conversion of the Aspen Preference Shares                                    
On 10 June 2012, the Aspen Preference Shares will convert into 17 600 000       
new Aspen Shares.                                                               
Aspen will apply for listing of the new Aspen Shares in Imithi`s name on the    
Main Board of the JSE Limited ("JSE"). It is expected that listing of the       
new Aspen Shares will take place on or shortly after 12 June 2012.              
4. Remaining Aspen Shares                                                       
Following the Sale and the conversion of the Aspen Preference Shares, Imithi    
will hold 21 160 724 Aspen Shares (the "Remaining Aspen Shares"),               
representing 4.65% of Aspen Shares in issue.                                    
The Remaining Aspen Shares are free from all debt and subject to a lockup on    
terms agreed between Imithi and Aspen until 10 June 2015.                       
The BEE Transaction has created meaningful economic value for Imithi,           
enabling the repayment of all acquisition funding in relation to its Aspen      
Shares, and retaining a residual, unencumbered shareholding of 4.65% in         
Aspen.                                                                          
Aspen remains committed to driving transformation in ways that are              
sustainable, credible and of benefit to all its stakeholders and to the         
country as a whole.                                                             
5. Directors interest                                                           
Dr NJ Dlamini, Aspen`s nonexecutive Chairman, has an indirect beneficial        
interest of 12% in Imithi.                                                      
Durban                                                                          
7 June 2012                                                                     
Sponsor:Investec Bank                                                           
Date: 07/06/2012 16:40:01 Produced by the JSE SENS Department.                  
The SENS service is an information dissemination service administered by the    
JSE Limited (`JSE`). The JSE does not, whether expressly, tacitly or            
implicitly, represent, warrant or in any way guarantee the truth, accuracy or   
completeness of the information published on SENS. The JSE, their officers,     
employees and agents accept no liability for (or in respect of) any direct,     
indirect, incidental or consequential loss or damage of any kind or nature,     
howsoever arising, from the use of SENS or the use of, or reliance on,          
information disseminated through SENS.                                          
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
Other Profile Group sites: FundsData Online (unit trust data)  |  Profile Group corporate site
Terms of Use |  Privacy Policy |  PAIA manual |  FAQs/Help |  Site Map |  © Copyright Reserved 2026  ]
  


Powered by ProfileData

Profile Mobile App Google Play Store Apple App Store


Follow us on: